publications

Illness during pregnancy presents a therapeutic dilemma: treatment must protect the mother without compromising fetal health. Yet, most drugs remain insufficiently studied in pregnancy. Understanding pregnancy stage-specific drug pharmacokinetics and placental drug transport can guide the design of nanomedicine to optimize treatments during pregnancy.

Herein, we propose a comprehensive investigation into two distinct milk types and a milk synthetic formula as potential enhancers of intestinal permeation, aiming to facilitate the oral delivery of liposomes and macromolecules.